Re: OTC Short Interest up 4.08% to 720,060 shr as of 12/31/21

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: OTC Short Interest up 4.08% to 720,060 shr as of 12/31/21

in response to

OTC Short Interest up 4.08% to 720,060 shr as of 12/31/21

fuzzyjr

posted on Jan 12, 2022 09:48AM

sorry wrong board, zen short interest remains unchanged sitting around 5500 shares....

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply